Search alternatives:
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
small decrease » small increased (Expand Search)
_ decrease » _ decreased (Expand Search), _ decreasing (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
small decrease » small increased (Expand Search)
_ decrease » _ decreased (Expand Search), _ decreasing (Expand Search)
-
1
-
2
-
3
-
4
Geographical distribution of large cities and small cities.
Published 2024“…The Figure reveals two patterns: 1) the maximum level of innovation is higher in large cities (2.53) than in small cities (2.02); 2) among large cities in <b>a</b>, innovation levels in general decrease with nightlight density. …”
-
5
Differentially expressed genes (DEGs)<sup>a</sup> showing the greatest fold changes from each potato tissue: 10 with greatest increase in expression and 10 with greatest decrease in expression.
Published 2025“…<p>Differentially expressed genes (DEGs)<sup>a</sup> showing the greatest fold changes from each potato tissue: 10 with greatest increase in expression and 10 with greatest decrease in expression.…”
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
Image 3_Exploration of the diagnostic and prognostic roles of decreased autoantibodies in lung cancer.tif
Published 2025“…Diagnosing malignant small lung nodules (≤3cm) in CT scans remains a challenge in clinical practice.…”
-
15
Data and code from: Continental declines in North American small mammal populations
Published 2025“…Contrary to our initial speculation, we found strong support for an overall decline in North American small mammal abundance, with an estimated annual decrease of 3.6%. …”
-
16
Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc
Published 2025“…The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”
-
17
-
18
-
19
-
20